Life Healthcare Group Holdings (LTGHF) Ratios
Life Healthcare Group Holdings Ratios
LTGHF's free cash flow for Q2 2026 was $313.77M. For the 2026 fiscal year, LTGHF's free cash flow was decreased by $-675.35M and operating cash flow was $989.12M. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.07 | 1.43 | 2.63 | 1.02 | 1.00 |
| Quick Ratio | 0.01 | 1.34 | 2.59 | 0.94 | 0.92 |
| Cash Ratio | 0.03 | 0.47 | 0.08 | 0.37 | 0.36 |
| Solvency Ratio | 1.97 | 0.56 | 0.05 | 0.11 | 0.15 |
| Operating Cash Flow Ratio | 0.03 | 0.71 | 0.02 | 0.55 | 0.70 |
| Short-Term Operating Cash Flow Coverage | 11.62 | 7.13 | 0.12 | 4.94 | 4.25 |
| Net Current Asset Value | $ -292.27M | $ -3.29B | $ 5.09B | $ -14.59B | $ -14.20B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 2.67 | 0.18 | 0.29 | 0.32 | 0.31 |
| Debt-to-Equity Ratio | 6.04 | 0.35 | 0.65 | 0.73 | 0.69 |
| Debt-to-Capital Ratio | 0.86 | 0.26 | 0.39 | 0.42 | 0.41 |
| Long-Term Debt-to-Capital Ratio | 0.83 | 0.18 | 0.34 | 0.36 | 0.33 |
| Financial Leverage Ratio | 2.26 | 1.94 | 2.26 | 2.25 | 2.26 |
| Debt Service Coverage Ratio | 31.48 | 4.12 | 1.23 | 2.14 | 2.05 |
| Interest Coverage Ratio | 6.38 | 6.87 | 4.22 | 7.74 | 4.74 |
| Debt to Market Cap | 0.17 | 0.25 | 0.43 | 0.42 | 0.48 |
| Interest Debt Per Share | 2.77 | 3.36 | 9.55 | 9.71 | 9.07 |
| Net Debt to EBITDA | 2.88 | 0.44 | 3.66 | 3.30 | 2.23 |
| Profitability Margins | |||||
| Gross Profit Margin | 23.29% | 69.78% | 28.31% | 20.82% | 68.24% |
| EBIT Margin | -1.14% | 12.34% | 10.87% | 8.22% | 10.79% |
| EBITDA Margin | 89.76% | 17.33% | 14.72% | 11.70% | 16.46% |
| Operating Profit Margin | 8.77% | 11.36% | 10.66% | 9.79% | 11.18% |
| Pretax Profit Margin | -2.47% | 10.69% | 8.35% | 7.77% | 8.96% |
| Net Profit Margin | 15.39% | 18.92% | 1.15% | 5.43% | 6.52% |
| Continuous Operations Profit Margin | -5.34% | 8.58% | 6.24% | 5.28% | 6.57% |
| Net Income Per EBT | -623.23% | 177.01% | 13.81% | 69.88% | 72.81% |
| EBT Per EBIT | -28.17% | 94.07% | 78.35% | 79.33% | 80.14% |
| Return on Assets (ROA) | 15.04% | 19.83% | 0.58% | 3.62% | 4.30% |
| Return on Equity (ROE) | 33.96% | 38.50% | 1.31% | 8.17% | 9.71% |
| Return on Capital Employed (ROCE) | -2.27% | 15.20% | 7.09% | 7.99% | 9.00% |
| Return on Invested Capital (ROIC) | -2.35% | 11.58% | 4.98% | 5.19% | 6.29% |
| Return on Tangible Assets | 16.54% | 23.24% | 0.62% | 5.95% | 7.19% |
| Earnings Yield | 1.14% | 36.27% | 0.95% | 5.74% | 8.44% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.55 | 6.60 | 6.79 | 8.56 | 8.68 |
| Payables Turnover | 9.65 | 3.99 | 9.40 | 4.22 | 3.83 |
| Inventory Turnover | 2.71 | 16.55 | 36.38 | 15.37 | 13.08 |
| Fixed Asset Turnover | 0.13 | 2.37 | 2.17 | 1.81 | 1.83 |
| Asset Turnover | 0.98 | 1.05 | 0.50 | 0.67 | 0.66 |
| Working Capital Turnover Ratio | -0.67 | 2.49 | 2.49 | 348.22 | -21.61 |
| Cash Conversion Cycle | 152.36 | -14.27 | 24.99 | -20.14 | -25.29 |
| Days of Sales Outstanding | 55.70 | 55.27 | 53.77 | 42.65 | 42.05 |
| Days of Inventory Outstanding | 134.49 | 22.06 | 10.03 | 23.75 | 27.92 |
| Days of Payables Outstanding | 37.83 | 91.59 | 38.82 | 86.54 | 95.25 |
| Operating Cycle | 190.19 | 77.33 | 63.80 | 66.41 | 69.96 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.16 | 2.58 | 0.15 | 2.93 | 3.54 |
| Free Cash Flow Per Share | 0.10 | 1.50 | 0.10 | 1.30 | 2.23 |
| Dividend Paid and CapEx Coverage Ratio | 0.59 | 0.34 | 2.22 | 1.44 | 2.71 |
| Capital Expenditure Coverage Ratio | 2.47 | 2.40 | 3.34 | 1.80 | 2.71 |
| Operating Cash Flow Coverage Ratio | 0.06 | 0.84 | 0.02 | 0.31 | 0.41 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.15 | 0.01 | 0.15 | 0.19 |
| Free Cash Flow Yield | 0.71% | 16.31% | 0.54% | 7.06% | 15.60% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 90.53 | 2.76 | 105.37 | 17.42 | 11.85 |
| Price-to-Sales (P/S) Ratio | 13.51 | 0.52 | 1.22 | 0.95 | 0.77 |
| Price-to-Book (P/B) Ratio | 29.81 | 1.06 | 1.38 | 1.42 | 1.15 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 141.01 | 6.13 | 186.28 | 14.16 | 6.41 |
| Price-to-Operating Cash Flow Ratio | 83.88 | 3.57 | 130.51 | 6.30 | 4.04 |
| Price-to-Earnings Growth (PEG) Ratio | -0.95 | 0.00 | -1.27 | -2.23 | 0.00 |
| Enterprise Value Multiple | 17.93 | 3.45 | 11.92 | 11.38 | 6.93 |
| Enterprise Value | 23.23B | 15.27B | 40.16B | 37.55B | 30.66B |
| EV to EBITDA | 17.93 | 3.45 | 11.92 | 11.38 | 6.93 |
| EV to Sales | 16.09 | 0.60 | 1.75 | 1.33 | 1.14 |
| EV to Free Cash Flow | 168.00 | 7.04 | 268.93 | 19.93 | 9.46 |
| EV to Operating Cash Flow | 99.94 | 4.10 | 188.43 | 8.87 | 5.96 |
| Tangible Book Value Per Share | 0.39 | 6.89 | 12.48 | 2.31 | 1.92 |
| Shareholders’ Equity Per Share | 0.46 | 8.69 | 14.02 | 12.96 | 12.43 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -1.16 | 0.20 | 0.25 | 0.32 | 0.27 |
| Revenue Per Share | 1.01 | 17.68 | 15.87 | 19.50 | 18.49 |
| Net Income Per Share | 0.15 | 3.34 | 0.18 | 1.06 | 1.21 |
| Tax Burden | -6.23 | 1.77 | 0.14 | 0.70 | 0.73 |
| Interest Burden | 2.18 | 0.87 | 0.77 | 0.94 | 0.83 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.84 | 0.06 | 0.05 | 0.03 | 0.03 |
| Stock-Based Compensation to Revenue | 0.24 | 0.01 | 0.00 | 0.01 | 0.00 |
| Income Quality | -0.37 | 1.37 | 3.23 | 1.71 | 1.97 |
Currency in ZAR
